Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430385
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Brief Title:
ATTUNE A Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 MECP2 Duplication Syndrome MDS
Sponsor:
Ionis Pharmaceuticals Inc
Organization:
Ionis Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Methyl CpG Binding Protein 2 MECP2 Duplication Syndrome |
Keywords: